HEALTH● LOWJul 2 · Jul 2, 2026, 12:28 PM
Roche lung cancer therapy beats rivals from Amgen, BMS in late-stage trial
Seeking Alpha Tech
Roche's lung cancer therapy demonstrated superior performance against rival treatments from Amgen and BMS in a late-stage clinical trial. This indicates a potential advance in lung cancer treatment.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH27m agoThe Expensive Mistake You're Making During Open Enrollment | Money Moves with Jill SchlesingerCBS NewsHEALTH1h agoActivists write open letter to Telangana CM, point at issues in govt hospitalsThe HinduHEALTH1h agoThailand and Vietnam meat seizures highlight deepening risk of unsafe food on the tableSouth China Morning PostHEALTH2h agoUpa Lokayukta finds expired food items in eateries in Belagavi bus standThe Hindu